Companies: 10,638     total market cap: NZ$233.480 T
๐Ÿ‡ฉ๐Ÿ‡ช Deutsch๐Ÿ‡ซ๐Ÿ‡ท Franรงais
$USD๐Ÿ‡บ๐Ÿ‡ธโ‚ฌEUR๐Ÿ‡ช๐Ÿ‡บโ‚นINR๐Ÿ‡ฎ๐Ÿ‡ณยฃGBP๐Ÿ‡ฌ๐Ÿ‡ง$CAD๐Ÿ‡จ๐Ÿ‡ฆ$AUD๐Ÿ‡ฆ๐Ÿ‡บ$HKD๐Ÿ‡ญ๐Ÿ‡ฐ$SGD๐Ÿ‡ธ๐Ÿ‡ฌ
Biogen
BIIB
#867
Rank
NZ$45.74 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ United States
Country
NZ$311.84
Share price
-0.47%
Change (1 day)
16.37%
Change (1 year)
๐Ÿ’Š Pharmaceuticals๐Ÿงฌ Biotech
Categories

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - Net assets

Net assets on the balance sheet as of September 2025 : NZ$31.46 Billion

According to Biogen's latest financial reports the company has NZ$31.46 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Biogen - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$NZ$29.63 B26.66%
2023-12-31$NZ$23.40 B10.98%
2022-12-31$NZ$21.08 B31.42%
2021-12-31$NZ$16.04 B8.34%
2020-12-31$NZ$14.81 B-25.23%
2019-12-31$NZ$19.80 B1.95%
2018-12-31$NZ$19.42 B9.52%
2017-12-31$NZ$17.73 B1.31%
2016-12-31$NZ$17.50 B27.83%
2015-12-31$NZ$13.69 B-0.76%
2014-12-31$NZ$13.80 B31.56%
2013-12-31$NZ$10.49 B23.93%
2012-12-31$NZ$8.46 B2.8%
2011-12-31$NZ$8.23 B16.58%
2010-12-31$NZ$7.06 B-18.07%
2009-12-31$NZ$8.62 B-14.24%
2008-12-31$NZ$10.05 B39.14%
2007-12-31$NZ$7.22 B-28.81%
2006-12-31$NZ$10.14 B0.45%
2005-12-31$NZ$10.10 B5.61%
2004-12-31$NZ$9.56 B-11.83%
2003-12-31$NZ$10.85 B411.73%
2002-12-31$NZ$2.12 B-34.72%
2001-12-31$NZ$3.24 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Amgen
AMGN
NZ$16.62 B-47.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$37.08 B 17.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
-NZ$4.5 Billion-114.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$160.88 B 411.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$137.00 B 335.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.33 Billion-101.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$149.13 B 373.97%๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Rad Laboratories
BIO
NZ$11.64 B-63.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$4.11 B-86.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$6.30 B-79.96%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

© 2025 CompaniesMarketcap.com